Literature DB >> 31994149

Identification of Flavonoids and Bufadienolides and Cytotoxic Effects of Kalanchoe daigremontiana Extracts on Human Cancer Cell Lines.

Justyna Stefanowicz-Hajduk1, Monika Asztemborska2, Mirosława Krauze-Baranowska3, Sylwia Godlewska3, Magdalena Gucwa1, Barbara Moniuszko-Szajwaj4, Anna Stochmal4, J Renata Ochocka1.   

Abstract

Kalanchoe species are well-known medicinal plants used in traditional medicine as anti-inflammatory and analgesic remedies. Recently, it has been reported that Kalanchoe plants have cytotoxic properties; however, data on traditional use of these plants in tumor treatment are extremely limited. Kalanchoe daigremontiana is one of the most popular species cultivated in Europe, and it is used, among other things, as a remedy in treating skin injuries and wounds. Studies on the biological activity of this species are scarce, and there is a lack of data on the cytotoxic activity of K. daigremontiana extracts on epithelial cancer cells in the literature. In our present study, we analyzed the phytochemical composition of K. daigremontiana ethanol extract and fractions-water and dichloromethane-by the HPLC-DAD-ESI-MS method and estimated cytotoxic activity of the extracts on human adenocarcinoma (HeLa), ovarian (SKOV-3), breast (MCF-7), and melanoma (A375) cell lines by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, real-time cell analyzer (RTCA), and flow cytometry. We identified 6 bufadienolide compounds and 19 flavonoids, mostly kaempferol, quercetin, isorhamnetin, and myricetin glycosides, of which only 3 flavonoids have been identified in K. daigremontiana to date. Other flavonoids that were characterized in our study have not yet been found in this plant. The ethanol extract and water fraction of K. daigremontiana did not show significant cytotoxic activity on the tested cell lines. In contrast, the dichloromethane fraction showed the strongest activity against all cell lines with IC50 values of ≤ 10 µg/mL. The results indicated that this activity is mainly due to the presence of bersaldegenin-1,3,5-orthoacetate. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 31994149     DOI: 10.1055/a-1099-9786

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

1.  Blood-Brain Barrier Permeability Study of Potential Neuroprotective Compounds Recovered From Plants and Agri-Food by-Products.

Authors:  José David Sánchez-Martínez; Alberto Valdés; Rocio Gallego; Zully Jimena Suárez-Montenegro; Marina Alarcón; Elena Ibañez; Gerardo Alvarez-Rivera; Alejandro Cifuentes
Journal:  Front Nutr       Date:  2022-06-16

2.  An In Vitro Anticancer, Antioxidant, and Phytochemical Study on Water Extract of Kalanchoe daigremontiana Raym.-Hamet and H. Perrier.

Authors:  Justyna Stefanowicz-Hajduk; Anna Hering; Magdalena Gucwa; Katarzyna Sztormowska-Achranowicz; Mariusz Kowalczyk; Agata Soluch; J Renata Ochocka
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

Review 3.  From Ethnomedicine to Plant Biotechnology and Machine Learning: The Valorization of the Medicinal Plant Bryophyllum sp.

Authors:  Pascual García-Pérez; Eva Lozano-Milo; Mariana Landin; Pedro P Gallego
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-04

4.  Machine Learning Unmasked Nutritional Imbalances on the Medicinal Plant Bryophyllum sp. Cultured in vitro.

Authors:  Pascual García-Pérez; Eva Lozano-Milo; Mariana Landin; Pedro Pablo Gallego
Journal:  Front Plant Sci       Date:  2020-12-01       Impact factor: 5.753

Review 5.  Potential of Kalanchoe pinnata as a Cancer Treatment Adjuvant and an Epigenetic Regulator.

Authors:  Marta Elena Hernández-Caballero; José Alfredo Sierra-Ramírez; Ricardo Villalobos-Valencia; Emmanuel Seseña-Méndez
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

6.  Biological activities of leaf extracts from selected Kalanchoe species and their relationship with bufadienolides content.

Authors:  Justyna Stefanowicz-Hajduk; Anna Hering; Magdalena Gucwa; Rafał Hałasa; Agata Soluch; Mariusz Kowalczyk; Anna Stochmal; Renata Ochocka
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.